Stay updated on Immunotherapy Combos with BMS-986179 in Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combos with BMS-986179 in Clinical Trial page.

Latest updates to the Immunotherapy Combos with BMS-986179 in Clinical Trial page
- Check4 days agoChange DetectedThe page header now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe study Locations section was updated to add sites in Illinois, Maryland, Massachusetts, New York, Pennsylvania, Tennessee, Texas, New South Wales, Victoria, Ontario, and Quebec, and to remove prior location entries; the revision note indicates a change from v3.3.2 to v3.3.3.SummaryDifference1%

- Check54 days agoChange DetectedRevision label in the page footer updated from v3.2.0 to v3.3.2. This change does not modify study details, navigation, or data on the page.SummaryDifference0.0%

- Check61 days agoChange DetectedThe government funding lapse banner was removed from the page; this is an administrative notice that did not alter the study details.SummaryDifference0.3%

- Check76 days agoChange DetectedNo additions or deletions were detected between the two screenshots. The Study Details page content appears unchanged.SummaryDifference0.3%

- Check104 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference4%

Stay in the know with updates to Immunotherapy Combos with BMS-986179 in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combos with BMS-986179 in Clinical Trial page.